Healthcare Sector Is Looking A Tad Better: M&A Boosts Biotech…Update-1
Update-1 "Growthier" market move sparked by housing data-new home sales jump 16.6% A broad rally today surprised many traders. Technology was a leader up 2% followed by healthcare up 1.49%. US new single family home sales hit an 8 year high a sign of growing prospects for the economy. The green...
Nothing New To Report: Green Screen Day…Update-1
Update: M&A will come back-- Pfizer (PFE) buys Anacor (ANAC) for $5.2B. Now you see why inversions are not good for biotech stocks as PFE had to give up reverse merger and go for growth. Last three posts are still on the mark. The 4% move today in XBI is encouraging ; the 6% move in...
On Vacation this week
Will try to post by weekend. Thank you for reading. IBB down 3% to 256. 5/11/16
Large Cap Biopharmaceuticals Q1 2016 Metrics: Earnings Show Limited Growth Prospects
Large Cap Biopharma Winners and Losers -Looking for Product Growth We will sift through these metrics and new product news over the coming months to find value in these names. Most should be considered "Market Performers" with some added safety if they offer dividends. Watch Regeneron (REGN)...
Biotech Bear Market: Another Bad Day IBB Down 2.9%…Update-1 Regeneron (REGN)
Update-1 May 5 ...Biotechs Stable Today...IBB up 0.45%, XBI down 0.53% Regeneron Pharmaceuticals (REGN) up 4.74% on sales growth,but missed on EPS. Regeneron (REGN) raised 2016 sales estimates for Eyelea(R) to a 20-25% increase based on Q1 sales of $781M. Total Revenues were $1.2B including...